2001, Número 1
<< Anterior Siguiente >>
Arch Cardiol Mex 2001; 71 (1)
Complicaciones de las válvulas protésicas cardiacas
Ferrans VJ, Loredo ML
Idioma: Español
Referencias bibliográficas: 14
Paginas: 10-12
Archivo PDF: 30.37 Kb.
RESUMEN
¿Existe la válvula protésica ideal? La variedad de diseños de las válvulas protésicas cardiacas disponibles para uso en pacientes indica claramente que tal no es el caso. Estos tipos de válvulas se pueden clasificar de la siguiente manera: 1) válvulas mecánicas: de disco, bivalvas, trivalvas y de bola; 2) válvulas de material polimérico, rígido o flexible; 3) válvulas bioprotésicas: de duramadre, válvula aórtica porcina y de pericardio parietal bovino; 4) biológicas: aloinjerto, autoinjerto y las fabricadas mediante ingeniería tisular.
REFERENCIAS (EN ESTE ARTÍCULO)
Chen W, Schoen FJ, Levy RJ: Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation 1994; 90: 323-329.
Fann JI, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB et al: Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg 1996; 62: 1301-1312.
Ferrans VJ, Spray TL, Billingham ME, Roberts WC: Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves. Transmission and scanning electron microscopic observations in 12 patients. Am J Cardiol 1978;41:1159-1184.
Hilbert SL, Ferrans VJ, Tomita Y, Eidbo EE, Jones M: Evaluation of explanted polyurethane trileaflet valves. J Thorac Cardiovasc Surg 1987; 94: 419-429.
Hilbert SL, Ferrans VJ, Jones M: Effects of preimplantation processing on bioprosthetic and biologic cardiac valve morphology. En: Cardiac Reconstructions with Allograft Valves. T Xenakis, ed. Springer-Verlag, New York, 1989: 65-94.
Hilbert SL, Ferrans VJ, Barrick MK: A comparison of porcine aortic valve fixation conditions using nondestructive polarized light microscopy. Transactions Society for Biomaterials, 1989: 115.
Hilbert SL, Jones M, Ferrans VJ: Flexible leaflet replacement heart valves. En: Encyclopedic handbook for biomaterials and applications. Part B: Applications. Wise D.L., (ed), New York. Marcel Dekker, 1995: 1111-1152.
Hilbert SL, Luna RE, Zhang J, Wang Y, Hopkins RA, Yu ZX, Ferrans VJ: Allograft heart valves: the role of apoptosis-mediated cell loss. J Thorac Cardiovasc Surg 1999; 117: 454-462.
Ishihara T, Ferrans VJ, Boyce SW, Jones M, Roberts WC: Structure and classification of cuspal tears and perforations in porcine bioprosthetic cardiac valves implanted in patients. Am J Cardiol 1981; 48: 665-678.
Jones M, Rodríguez ER, Eidbo EE, Ferrans VJ: Cuspal perforations caused by long suture ends in implanted bioprosthetic valves. J Thorac Cardiovasc Surg 1985; 90: 557-563.
O’Brien MF, Stafford EG, Gardner AH, Pohiner PG, Tesar PJ, Cochrane AD et al: Allograft aortic valve replacement: long-term follow-up. Ann Thorac Surg 1995; 60: S65-70.
Poirier NC, Pelletier LC, Pellerin M, Carrier M: 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg 1998; 66: S57-61.
Schoen FJ, Golomb G, Levy RJ: Calcification of bioprosthetic heart valves: a perspective on models. J Heart Valve Dis 1992; 1: 110-114.
Zellner JL, Kratz JM, Crumbley AJ, Stround MR, Bradley SM, Sade RM et al: Long-term experience with the St. Jude medical valve prosthesis. Ann Thorac Surg 1999; 68: 1210-1218.